Chapter title |
New biologic agents for the treatment of cutaneous T-cell lymphoma.
|
---|---|
Chapter number | 37 |
Book title |
Cancers of the Skin
|
Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2002
|
DOI | 10.1007/978-3-642-59410-6_37 |
Pubmed ID | |
Book ISBNs |
978-3-64-263969-2, 978-3-64-259410-6
|
Authors |
Vittorio, Carmela C, Junkins-Hopkins, Jacqueline M, McGinnis, Karen S, Shapiro, Michael, Wysocka, Maria, Zaki, Mohamed H, French, Lars E, Rook, Alain H, Carmela C. Vittorio, Jacqueline M. Junkins-Hopkins, Karen S. McGinnis, Michael Shapiro, Maria Wysocka, Mohamed H. Zaki, Lars E. French, Alain H. Rook, Vittorio, Carmela C., Junkins-Hopkins, Jacqueline M., McGinnis, Karen S., Zaki, Mohamed H., French, Lars E., Rook, Alain H. |
Abstract |
Cutaneous T-cell lymphoma (CTCL) is typically a skin-infiltrating malignancy of clonally derived CD4+ T lymphocytes. Because the host antitumor response appears to play an important role in disease control, systemic therapeutic agents are used in such a manner as to preserve the integrity of the host antitumor response while selectively targeting the malignant cells. The new biologic response-modifying treatment options currently used to treat CTCL are reviewed. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor | 1 | 50% |
Researcher | 1 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 50% |
Medicine and Dentistry | 1 | 50% |